CD274 and neoplasm: Another study using melanoma models showed that SASP-induced IL-1β release elevated PD-L1 levels in tumor cells, establishing an immunosuppressive barrier that diminished the effectiveness of checkpoint inhibitor therapies such as anti-PD-1 therapy [79] (Figure 4; original work by authors).